Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Cannabis

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Phase 1 (1)
Phase 2 (1)

Trial Status

Recruiting1
Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06859723Phase 1RecruitingPrimary

High Potency Cannabis: Acute and Protracted Effects

NCT03656029Phase 2Completed

Dose-response of Cannabis and Driving

Showing all 2 trials

Research Network

Common Treatments

  • Cannabis1
  • Dronabinol1

Active Sponsors

  • Centre for Addiction and Mental Health1
  • California Department of Cannabis Control (DCC)1
  • University of California, Los Angeles1

Top Investigators

Related Conditions

  • Cognitive Impairment1
  • Driving Impaired1
  • Pain1
  • Pharmacokinetics1

Activity Timeline